Vault-13

NEWAMSTERDAM PHARMA COMPANY NAMS

ORDINARY SHARES · Common Stock · CUSIP N62509109

15 institutional holders
33,516,83633.5m shares reported held*
41.1% of all shares outstanding*
$362.2mreported value*

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 81.6m as of 2022-12-31, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $10.81.

Biggest buyers

Frazier Life Sciences Management, L.P. New +9,341,551+9.3m
Bain Capital Life Sciences Investors, LLC New +8,300,000+8.3m
RA CAPITAL MANAGEMENT, L.P. New +4,000,000+4.0m
VIKING GLOBAL INVESTORS LP New +3,753,828+3.8m
DEERFIELD MANAGEMENT COMPANY, L.P. New +2,480,199+2.5m
Medicxi Ventures Management (Jersey) Ltd New +2,000,000+2.0m
BVF INC/IL New +1,521,948+1.5m
GMT Capital Corp New +1,000,000+1.0m
JANUS HENDERSON GROUP PLC New +563,119+563.1k
Ensign Peak Advisors, Inc New +355,000+355.0k

Biggest sellers

None

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
Capital World Investors 13G · institution +1.7 pts · filed 2026-06-04 10.4% +1.7 pts 12.2m≈ $413.1m 2026-06-04
RA CAPITAL MANAGEMENT, L.P. 13G · passive investor no change · filed 2025-05-15 9.9% no change 11.1m≈ $374.9m 2025-05-15
FMR LLC 13G · institution +1.2 pts · filed 2026-08-06 8.8% +1.2 pts 10.3m≈ $350.4m 2026-08-06
Frazier Life Sciences X, L.P. 13D · may seek influence +1.0 pts · filed 2026-09-22 8.7% +1.0 pts 10.4m≈ $353.3m 2026-09-22
Forbion Capital Fund IV Cooperatief U.A. 13D · may seek influence -1.1 pts · filed 2025-09-30 8.3% -1.1 pts 9.3m≈ $315.8m 2025-09-30

Fell to 5% or below in the last year: BCLS II Investco, LP (1.8%, 2026-05-14), VIKING GLOBAL INVESTORS LP (3.7%, 2026-02-17)

Insider purchases and sales in Q4 2022

Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.

None reported in Q4 2022.

Holders, Q4 2022

#ManagerLocationShares Value% of their portfolioChangeShares change
1 Frazier Life Sciences Management, L.P. 6.33% of their portfolio PALO ALTO, CA 9,341,5519.3m $101.8m $101.8m 6.33% New
2 Bain Capital Life Sciences Investors, LLC 10.11% of their portfolio Boston, MA 8,300,0008.3m $90.5m $90.5m 10.11% New
3 RA CAPITAL MANAGEMENT, L.P. 0.88% of their portfolio BOSTON, MA 4,000,0004.0m $43.6m $43.6m 0.88% New
4 VIKING GLOBAL INVESTORS LP 0.20% of their portfolio STAMFORD, CT 3,753,8283.8m $39.5m $39.5m 0.20% New
5 DEERFIELD MANAGEMENT COMPANY, L.P. 0.56% of their portfolio New York, NY 2,480,1992.5m $27.0m $27.0m 0.56% New
6 Medicxi Ventures Management (Jersey) Ltd 9.16% of their portfolio ST. HELIER, Y9 2,000,0002.0m $21.8m $21.8m 9.16% New
7 BVF INC/IL 0.68% of their portfolio San Francisco, CA 1,521,9481.5m $16.0m $16.0m 0.68% New
8 GMT Capital Corp 0.50% of their portfolio ATLANTA, GA 1,000,0001.0m $10.9m $10.9m 0.50% New
9 JANUS HENDERSON GROUP PLC 0.00% of their portfolio LONDON, X0 563,119563.1k $5.3m $5.3m 0.00% New
10 Ensign Peak Advisors, Inc 0.01% of their portfolio SALT LAKE CITY, UT 355,000355.0k $3.9m $3.9m 0.01% New
11 Alyeska Investment Group, L.P. 0.02% of their portfolio CHICAGO, IL 200,000200.0k $1.9m $1.9m 0.02% New
12 JPMORGAN CHASE & CO 0.00% of their portfolio NEW YORK, NY 1,1021.1k $12.0k $12.0k 0.00% New
13 Tower Research Capital LLC (TRC) 0.00% of their portfolio NEW YORK, NY 8888 $1.0k $1.0k 0.00% New
14 DUPONT CAPITAL MANAGEMENT CORP 0.00% of their portfolio Wilmington, DE 11 $11 $11 0.00% New
15 CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio BIRMINGHAM, AL 00 $0 $0 0.00% New